World Class Speakers

The World Biosimilar Congress agenda will feature 300+ speakers across multiple streams.

Speakers will come from the most successful, innovative and thought-provoking companies from around the world. They will be supported by leading suppliers from the mega tech companies to the latest start-ups who are shaking up the industry.

 

APPLY TO SPEAK

 

Meet our 2017 speakers

Tudor Arvinte, President and Chief Executive Officer, Therapeomic Inc

Tudor Arvinte at World Biosimilar Congress

Philip Ball, Market Access Manager, Napp Pharmaceuticals

Philip Ball at World Biosimilar Congress

Fereshteh Barei, Health Economist, LEGOS Paris Dauphine University

Fereshteh Barei at World Biosimilar Congress

Dr Alain Beck, Senior Director, NBEs Analytical Chemistry, Centre d'Immunologie Pierre Fabre

Dr Alain Beck at World Biosimilar Congress

Caroline Boulliat, Immunology, Oncology. Biosimilar Business Unit Head, Amgen Europe Gmbh

Caroline Boulliat at World Biosimilar Congress

Joanna Brougher, Owner & Principal, BioPharma Law Group, PLLC, Biotech, Pharma and Medical Device IP and Corporate Co, BioPharma Law Group PLLC

Joanna Brougher at World Biosimilar Congress

Divya Chadha Manek, Head of Business Development (Commercial), National Institute for Health Research (NIHR)

Divya Chadha Manek at World Biosimilar Congress

Dan Cimpoeru, Board Member, European Cancer Patient Coalition

Dan Cimpoeru at World Biosimilar Congress

Anne Cook, Biologicals Quality Assessor, M.H.R.A.

Anne Cook at World Biosimilar Congress

Margaret Dolan, Regional Pharmacy Procurement Specialist, N.H.S.

Margaret Dolan at World Biosimilar Congress

Pieter Dylst, Senior Manager Market Access, Medicines for Europe

Pieter Dylst at World Biosimilar Congress

Catherine Evans, Business Development Manager for Biopharma, Bruker U.K. Ltd

Catherine Evans at World Biosimilar Congress

Mathias Flume, Head of Drug Department, Kassenarztliche Vereinigung Westfalen-Lippe

Mathias Flume at World Biosimilar Congress

Francois Xavier Frapaise MD, CMO, Merck Biosimilars

Francois Xavier Frapaise MD at World Biosimilar Congress

Uwe Gudat, Head of Safety, Biosimilars, Merck & Cie

Uwe Gudat at World Biosimilar Congress

Jatinder Harchowal, Jatinder Harchowal Chief Pharmacist / Clinical Director, Medicines Management & Clinical Support Services Business Unit, Royal Marsden NHS Foundation Trust

Jatinder Harchowal at World Biosimilar Congress

Ian Henshaw, Head of Business Operations, Biogen

Ian Henshaw at World Biosimilar Congress

Forrest Hu, General Manager of International Business, 3SBio Inc

Forrest Hu at World Biosimilar Congress

Ruediger Jankowsky, Managing Director, Cinfa Biotech

Ruediger Jankowsky at World Biosimilar Congress

Peter Jorgensen, Chief Executive Officer, I.G.L.

Peter Jorgensen at World Biosimilar Congress

Parminder Kaur, CEO, RegPak BioPharma Consulting

Parminder Kaur at World Biosimilar Congress

Tarek Kilani, Former Head of Pharmacy & Continuing Medical Education Coordinator, Emirates French Hospital Llc

Tarek Kilani at World Biosimilar Congress

Martin Knight, Sr. Director, Strategy & Planning, Inflammation, Infectious Disease and General Medicine, Covance

Martin Knight at World Biosimilar Congress

Jenny Koppelkamm, Market Access Director, Takeda

Jenny Koppelkamm at World Biosimilar Congress

William Christopher Lamanna, Laboratory Head of Protein Characterization, Sandoz Inc

William Christopher Lamanna at World Biosimilar Congress

Adam Levysohn, Head of Global Market Access Biogen Biosimilars Business Unit, Biogen

Adam Levysohn at World Biosimilar Congress

Patrick Liu, Vice President of Global Biologics R&D and Head of Biologics, Assays and Technology, Teva Pharmaceuticals U.S.A.

Patrick Liu at World Biosimilar Congress

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen at World Biosimilar Congress

Márcia Martini Bueno, Institucional Affairs Director, Libbs Pharmaceutica Ltda

Márcia Martini Bueno at World Biosimilar Congress

Victor Lino Mendonça, VP Global Policy & Market Access Europe, Mylan

Victor Lino Mendonça at World Biosimilar Congress

Gopalan Narayanan, VP, Complex Bio, Voisin Consulting Life Sciences (VCLS)

Gopalan Narayanan at World Biosimilar Congress

Cecil Nick, Vice President, PAREXEL

Cecil Nick at World Biosimilar Congress

Ber Oomen, Executive Secretary and Treasurer, ‎European Specialist Nurses Organisations

Ber Oomen at World Biosimilar Congress

Mareike Ostertag, Director Regulatory and Science Policy, Novartis Pharma AG

Mareike Ostertag at World Biosimilar Congress

Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines

Michael Reilly at World Biosimilar Congress

Joaquin Rodrigo, Founder President, BIOSIM Spanish Association of Biosimilars

Joaquin Rodrigo at World Biosimilar Congress

Dr Stacie Ropka, Partner, Axinn

Dr Stacie Ropka at World Biosimilar Congress

Karsten Roth, Director Clinical Operations, Cinfa Biotech

Karsten Roth at World Biosimilar Congress

Ingrid Schwarzenberger, Head of Global Regulatory Affairs Biopharmaceuticals, Sandoz Biopharmaceuticals Gmbh

Ingrid Schwarzenberger at World Biosimilar Congress

Anjan Selz, Vice President – Head of Biosimilars EMEA, Lupin Europe Ltd

Anjan Selz at World Biosimilar Congress

Tim Shea, Director, Sterne Kessler Goldstein And Fox Plc

Tim Shea at World Biosimilar Congress

Shantreddy Soogareddy, Associate Director - External Development R&D (Alliance and Project management), Dr. Reddy's Laboratories Limited

Shantreddy Soogareddy at World Biosimilar Congress

George Stefanov, Marketing Operations Director Biologics, Europe, Mylan

George Stefanov at World Biosimilar Congress

Don Stewart, President and Chief Executive Officer, PlantForm Corporation

Don Stewart at World Biosimilar Congress

Gianluca Trifirò, Assistant Professor of Pharmacology, University of Messina

Gianluca Trifirò at World Biosimilar Congress

Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz

Florian Turk at World Biosimilar Congress

Jonathan Underhill, Associate Director for Medicines Evidence, NICE

Jonathan Underhill at World Biosimilar Congress

Manfred Weiler, Senior Vice President, Medical & Scientific Strategy, INC Research

Manfred Weiler at World Biosimilar Congress

Robert Wojciechowski, Vice President, Global Regulatory Consulting, INC Research/inVentiv Health

Robert Wojciechowski at World Biosimilar Congress

Elena Wolff-Holz, Elena Wolff-Holz, Chair, Biosimilar Medicinal Products Working Party (BMWP), Paul Ehrlich Institut

Elena Wolff-Holz at World Biosimilar Congress

René Wuttke, Bioanalytical Principal Investigator, Global Bioanalytical Services, Celerion Inc.

René Wuttke at World Biosimilar Congress

 

Co-located with 

Part of


World Biosimilar Congress 29-30 October, Basel, Switzerland

Part of the  Festival of Biologics

Sign Up for Event Updates